-+ 0.00%
-+ 0.00%
-+ 0.00%

Aoxin Q & M Dental Group (Catalist:1D4) Stock Confronts Profit Squeeze

Simply Wall St·08/14/2026 11:35:12
Listen to the news

Aoxin Q & M Dental Group’s share price barely budged into these results, even though the latest half year figures handed investors a sharp sentiment check. Revenue for H1 2026 came in at ¥79.02m while net income was only ¥0.351m. That left basic earnings per share at just ¥0.0003.

For a stock already trading on a rich price to sales multiple, this kind of profit squeeze can affect bullish confidence. The question now is whether the market treats this as a blip in a still profitable story or the start of a rethink on what Aoxin Q & M Dental Group is worth.

Is Aoxin Q & M Dental Group now priced for perfection or already stretching its fundamentals at this rich P/S multiple? You can compare the current market tag with the underlying cash flows in the valuation analysis for Aoxin Q & M Dental Group

H1 2026 Earnings Summary

  • Revenue H1 2026 vs. H1 2025: ¥79.02m vs. ¥88.512m (down about 10.7%)
  • Net Income H1 2026 vs. H1 2025: ¥0.351m vs. ¥2.736m (down about 87.2%)
  • Basic EPS H1 2026 vs. H1 2025: ¥0.0003 vs. ¥0.005348 (down about 94.4%)
  • Trailing 12 Month Revenue to H1 2026 vs. TTM to H1 2025: ¥165.629m vs. ¥190.531m (down about 13.0%)

Prefer clear visuals instead of another wall of earnings tables and ratios? Get the full Aoxin Q & M Dental Group picture, including a simple snapshot of its recent earnings trend, through the company report for Aoxin Q & M Dental Group.

Catalist:1D4 Trailing 12-Month Revenue & Expenses Breakdown as at Aug 2026
Catalist:1D4 Trailing 12-Month Revenue & Expenses Breakdown as at Aug 2026

Aoxin Q & M Bullish Story Faces Profit Reality

The vertically integrated pitch at Aoxin Q & M Dental Group leans on recurring dental demand and multiple revenue streams. The latest numbers make that story harder to lean on. Revenue over the trailing 12 months slipped from ¥190.531m to ¥165.629m and H1 2026 net income dropped to ¥0.351m. Earnings per share are now close to flat. For a healthcare platform that investors often see as relatively steady, these figures suggest the business model is under pressure rather than clearly reinforcing a bullish narrative.

Bearish Concerns On Margins Look More Justified

If you have been worried about margin compression or China related operating risk at Aoxin Q & M Dental Group, these results do not ease that concern. Net income for H1 2026 fell much faster than revenue, from ¥2.736m to ¥0.351m, and trailing 12 month revenue is also lower. That combination points to both softer top line and weaker profitability. Recent share price performance, with the stock down over the last 3 months, aligns with a market that is already treating these pressures as more than just noise.

Compare Aoxin Q & M Dental Group’s recent profit squeeze with what institutional forecasts are signaling, and see whether the latest SGD0.235 share price lines up with analyst expectations through the consensus price target analysis for Aoxin Q & M Dental Group.

Stay Ahead With Simply Wall St

If the recent profit squeeze at Aoxin Q & M Dental Group has you weighing whether the current share price still matches the fundamentals, register for free with Simply Wall St and add the stock to your Watchlist to track price against fair value and wait for a setup that suits you. Once you do own it, keep your decisions clear with the Portfolio Command Center that focuses your attention on the most important changes to your holdings. For a longer term view, tap into the crowd insight inside the Community and compare your thesis with other investors. This way you give yourself a better chance of spotting hidden catalysts and risks early and staying a step ahead of the market.

Seeking Alternatives Beyond Aoxin Q & M

The next breakout ideas rarely wait. Fresh momentum can move fast, and under the radar stories do not stay quiet for long. Scan these focused stock shortlists and consider acting early.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.